JP7312341B2 - パーキンソン病症状の改善又は予防のための組成物 - Google Patents

パーキンソン病症状の改善又は予防のための組成物 Download PDF

Info

Publication number
JP7312341B2
JP7312341B2 JP2019119708A JP2019119708A JP7312341B2 JP 7312341 B2 JP7312341 B2 JP 7312341B2 JP 2019119708 A JP2019119708 A JP 2019119708A JP 2019119708 A JP2019119708 A JP 2019119708A JP 7312341 B2 JP7312341 B2 JP 7312341B2
Authority
JP
Japan
Prior art keywords
hydrogen
disease
parkinson
symptoms
gas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019119708A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020079227A (ja
Inventor
文武 佐藤
伸一 平野
亮介 黒川
宜達 謝
将貢 齋藤
祐介 市川
赳郎 竹越
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Miz Co Ltd
Original Assignee
Miz Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miz Co Ltd filed Critical Miz Co Ltd
Publication of JP2020079227A publication Critical patent/JP2020079227A/ja
Priority to JP2021083004A priority Critical patent/JP2021113239A/ja
Application granted granted Critical
Publication of JP7312341B2 publication Critical patent/JP7312341B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2019119708A 2018-06-29 2019-06-27 パーキンソン病症状の改善又は予防のための組成物 Active JP7312341B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021083004A JP2021113239A (ja) 2018-06-29 2021-05-17 パーキンソン病症状の改善又は予防のための組成物

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2018125228 2018-06-29
JP2018125228 2018-06-29
JP2018216264 2018-11-19
JP2018216264 2018-11-19

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021083004A Division JP2021113239A (ja) 2018-06-29 2021-05-17 パーキンソン病症状の改善又は予防のための組成物

Publications (2)

Publication Number Publication Date
JP2020079227A JP2020079227A (ja) 2020-05-28
JP7312341B2 true JP7312341B2 (ja) 2023-07-21

Family

ID=69054942

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019119708A Active JP7312341B2 (ja) 2018-06-29 2019-06-27 パーキンソン病症状の改善又は予防のための組成物
JP2021083004A Pending JP2021113239A (ja) 2018-06-29 2021-05-17 パーキンソン病症状の改善又は予防のための組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021083004A Pending JP2021113239A (ja) 2018-06-29 2021-05-17 パーキンソン病症状の改善又は予防のための組成物

Country Status (2)

Country Link
US (1) US20200000843A1 (https=)
JP (2) JP7312341B2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6971486B2 (ja) * 2019-06-10 2021-11-24 ＭｉＺ株式会社 脊椎・脊髄損傷の症状を改善するための組成物
US20210402211A1 (en) * 2020-06-24 2021-12-30 Hung-Yu Lin Light-hydrogen therapy including lighting module, lighting apparatus, and lighting method for parkinson's disease patients
JP7019910B2 (ja) * 2020-07-21 2022-02-16 ＭｉＺ株式会社 薬の副作用、薬の副作用に関連する症状、および／または、治療に伴う副作用を予防および／または改善するための組成物
JP2024099077A (ja) * 2022-01-24 2024-07-25 ＭｉＺ株式会社 ウイルス感染症の後遺症の改善および／または症状の悪化を抑制するのための組成物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015183004A (ja) 2014-03-25 2015-10-22 リン, シン−ユンLin, Hsin−Yung パーキンソン病を治療するための吸入式医薬組成物及びその調製法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015183004A (ja) 2014-03-25 2015-10-22 リン, シン−ユンLin, Hsin−Yung パーキンソン病を治療するための吸入式医薬組成物及びその調製法

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
Ｃｅｌｌ Ｔｉｓｓｕｅ Ｒｅｓ，２００４年，Ｖｏｌ．３１８，ｐ．２１５－２２４
Ｍｅｄｉｃａｌ Ｇａｓ Ｒｅｓｅａｒｃｈ，２０１２年，Ｖｏｌ．２，Ｎｏ．１５，ｐ．１－７
Ｍｅｔｈｏｄｓ ｉｎ Ｅｎｚｙｍｏｌｏｇｙ，２０１５年，Ｖｏｌ．５５５，ｐ．２８９－３１７
Ｍｏｖｅｍｅｎｔ Ｄｉｓｏｒｄｅｒｓ，２０１３年，Ｖｏｌ．２８，ｐ．８３６－８３９
Ｏｘｉｄａｔｉｖｅ Ｍｅｄｉｃｉｎｅ ａｎｄ Ｃｅｌｌｕｌａｒ Ｌｏｎｇｅｖｉｔｙ，２０１２年，Ｖｏｌ．２０１２，ｐ．１－１１
Ｐｓｙｃｈｏｐｈａｒｍａｃｏｌｏｇｙ，２００８年，Ｖｏｌ．１９９，ｐ．３０３－３１２
ＳＡＧＥ Ｈｉｎｄａｗｉ Ａｃｃｅｓｓ ｔｏ Ｒｅｓｅａｒｃｈ Ｐａｒｋｉｎｓｏｎ’ｓ Ｄｉｓｅａｓｅ，２０１１年，Ｖｏｌｕｍｅ２０１１，Ａｒｔｉｃｌｅ ＩＤ６５８０８３
アンチ・エイジング医学－日本抗加齢医学会雑誌，２０１１年，Ｖｏｌ．７，Ｎｏ．３，ｐ．５８－６７
医学のあゆみ，２２５巻，５号，２００８年，ｐ．３６５－３７２
深井有著「水素分子はかなりすごい 生命科学と医療効果の最前線」２０１７年初版第１刷（株）光文社発行 ｐ．５６－５７、９０－９３

Also Published As

Publication number Publication date
JP2021113239A (ja) 2021-08-05
JP2020079227A (ja) 2020-05-28
US20200000843A1 (en) 2020-01-02

Similar Documents

Publication Publication Date Title
JP7312341B2 (ja) パーキンソン病症状の改善又は予防のための組成物
JP2022136154A (ja) 統合失調症治療用組成物
JP6739846B2 (ja) うつ症状を改善するための水素含有組成物
JP2022159439A (ja) 術後回復を促進するための分子状水素含有組成物
JP6972449B2 (ja) 炎症性腸疾患を予防および／または改善するための分子状水素含有組成物
JP6628449B1 (ja) 閉塞性気道疾患の抑制又は軽減のための組成物
US20200384013A1 (en) Composition for improvement of symptoms of spinal cord injury
US20210275576A1 (en) Molecular hydrogen-containing composition for prevention and/or improvement of genetic disorder
JP7455293B2 (ja) 脳卒中後の後遺症改善のための組成物
JP7312340B2 (ja) 水素を含む加齢黄斑変性治療用組成物
JP2022136069A (ja) 骨粗しょう症の予防又は改善をするための分子状水素含有組成物
US20230256007A1 (en) Composition for improving sequelae of viral infection and/or reducing worsening of symptoms
JP2022049676A (ja) 慢性炎症を予防および／または改善するための分子状水素含有組成物
JP7414203B2 (ja) 痛風の改善および／または症状の悪化を抑制するのための組成物
CN113318123A (zh) 用于预防和/或改善肺炎的含分子态氢组合物
JP7366331B2 (ja) 臓器特異的自己免疫疾患を予防および／または改善するのための組成物および方法
JP7409586B2 (ja) 筋痛性脳脊髄炎／慢性疲労症候群（ｍｅ／ｃｆｓ）および／または線維筋痛症（ｆｍ）の改善および／または症状の悪化を抑制するのための組成物
JP2021151980A (ja) 脳炎および／または髄膜炎と当該脳炎および／または髄膜炎に関連する症状を予防および／または改善するための分子状水素含有組成物
JP7220339B1 (ja) 突発性難聴の改善および／または症状の悪化を抑制するのための組成物
JP2024072231A (ja) 筋萎縮性側索硬化症（ａｌｓ）および／またはａｌｓに関連する症状を予防、または、改善するのための組成物および方法
JP2023107764A6 (ja) ウイルス感染症の後遺症の改善および／または症状の悪化を抑制するのための組成物
Sia et al. Case Report: Gamma‐Hydroxybutyrate Poisoning
JP2024004427A (ja) ワクチン接種後の副反応を予防、または、改善するのための組成物および方法
SNELL et al. M. SAMBROOK
EP1931410A1 (en) Method to increase and accelerated rehabilitate the capacity for work

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20201027

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20201027

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20201110

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20201201

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210128

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20210216

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20210409

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20210419

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210517

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20210517

C11 Written invitation by the commissioner to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C11

Effective date: 20210526

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20210624

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20210804

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20210805

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20210820

C211 Notice of termination of reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C211

Effective date: 20210824

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20220920

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20221005

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20221129

C13 Notice of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: C13

Effective date: 20221213

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221214

C23 Notice of termination of proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C23

Effective date: 20230404

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230522

R150 Certificate of patent or registration of utility model

Ref document number: 7312341

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150